ARCHIVES

Phase II Study Tests Chemo Plus Mylotarg For AML

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

DCT Board Oks Limited Support For Development Of Neutron Therapy

March 31, 1978

Without Advisor’s Input, Healy Approves Protocol For Gene Therapy

January 15, 1993

In Brief: Subcommittee Adds $16-18 Million o NVI Budget; Upton Might Leave If Bill Fails

May 25, 1979

NCI, NHGRI plan $100-million, three-year feasibility test for cancer genome project. NCI to establish biospecimen office.

September 23, 2005

New Grants In Ovarian Cancer Ok’d In Concepts By DCBDC Advisors

March 27, 1992

GI Intergroup called a model for proposed scientific steering committees.

June 10, 2005